A woman receives an injection during phase 3 testing for the Johnson & Johnson vaccine candidate.
Johnson & Johnson via AP
Johnson & Johnson has paused clinical trials for its COVID-19 vaccine candidate after an unexplained illness by a participant
The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and enrollment has been halted, citing “an unexplained illness in a study participant.”